Finnrick - Ensuring a Safer and More Transparent Supply Chain
Xingruida XDR

Xingruida XDR
Tirzepatide

Finnrick tested 2 samples of Tirzepatide (GLP-1 and GIP antagonist) from Xingruida XDR on 4 Sep 2025. Test scores average over 7, no score below 6, and at least 2 tests warrant a tentative Finnrick Rating of A (Great).

Finnrick Rating™
A
GREAT
Tentative Rating
Xingruida XDR
Tirzepatide
Tested 2 Samples
Last test 4 Sep 2025

Take Action

Researcher

Request Full Data Access to the Finnrick database of peptide tests.

Free peptide testing

Mail in a sample (US only) to get confidence for the specific vials you have, and contribute to identifying unsafe supply chains, so other people can avoid risky and costly mistakes.

All Tirzepatide tests from Xingruida XDR

Samples are tested in commercial labs

Tests Count

2

Scores

AVG9.0MIN8.0MAX10.0

Last

4 Sep 2025
Quantity
Test DateCertificate
Test Score
LabelTestedDifferencePurityBatch IDContainerTested AtSent By
4 Sep 2025View8.020mg19.100mg-4.5%99.95%(no batch ID)Purple Label / Silver Crimp / Purple CapLab EPublic
4 Sep 2025View10.030mg30.100mg+0.3%99.95%July 2 2025 White Label / Silver Crimp / Pink Cap Lab EPublic